308 related articles for article (PubMed ID: 26802722)
21. Systemic sclerosis and the gut.
Butt S; Emmanuel A
Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):331-9. PubMed ID: 23639091
[TBL] [Abstract][Full Text] [Related]
22. [How to recognize scleroderma].
Francès C; Ayoub N; Barete S
Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
[TBL] [Abstract][Full Text] [Related]
23. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
Steen VD; Medsger TA
Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
[TBL] [Abstract][Full Text] [Related]
25. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
26. Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment.
Affandi AJ; Radstake TR; Marut W
Semin Immunopathol; 2015 Sep; 37(5):475-87. PubMed ID: 26168983
[TBL] [Abstract][Full Text] [Related]
27. Advances in the diagnosis and management of scleroderma-related vascular complications.
Kerin K; Yost JH
Compr Ther; 1998; 24(11-12):574-81. PubMed ID: 9847974
[TBL] [Abstract][Full Text] [Related]
28. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
Jimenez SA; Piera-Velazquez S
Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
[TBL] [Abstract][Full Text] [Related]
29. Lung transplantation in patients with scleroderma.
De Cruz S; Ross D
Curr Opin Rheumatol; 2013 Nov; 25(6):714-8. PubMed ID: 24061075
[TBL] [Abstract][Full Text] [Related]
30. Update on systemic sclerosis.
McCray CJ; Mayes MD
Curr Allergy Asthma Rep; 2015 May; 15(5):25. PubMed ID: 26139334
[TBL] [Abstract][Full Text] [Related]
31. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
32. New insights into the recognition, classification and management of systemic sclerosis-associated pulmonary hypertension.
Mullin CJ; Mathai SC
Curr Opin Rheumatol; 2017 Nov; 29(6):561-567. PubMed ID: 28817465
[TBL] [Abstract][Full Text] [Related]
33. [Lung involvement in systemic sclerosis].
Posa M; Stelle M; Lador F; Chizzolini C
Rev Med Suisse; 2015 Apr; 11(469):802-6. PubMed ID: 26040160
[TBL] [Abstract][Full Text] [Related]
34. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels.
Smeets RL; Kersten BE; Joosten I; Kaffa C; Alkema W; Koenen HJPM; Vonk MC
Autoimmun Rev; 2020 May; 19(5):102515. PubMed ID: 32173517
[TBL] [Abstract][Full Text] [Related]
36. Systemic sclerosis: Recent insight in clinical management.
Zanatta E; Codullo V; Avouac J; Allanore Y
Joint Bone Spine; 2020 Jul; 87(4):293-299. PubMed ID: 31568838
[TBL] [Abstract][Full Text] [Related]
37. Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort.
Hoffmann-Vold AM; Midtvedt Ø; Tennøe AH; Garen T; Lund MB; Aaløkken TM; Andreassen AK; Elhage F; Brunborg C; Taraldsrud E; Molberg Ø
J Rheumatol; 2017 Apr; 44(4):459-465. PubMed ID: 28089974
[TBL] [Abstract][Full Text] [Related]
38. A methodology for exploring biomarker--phenotype associations: application to flow cytometry data and systemic sclerosis clinical manifestations.
Huang H; Fava A; Guhr T; Cimbro R; Rosen A; Boin F; Ellis H
BMC Bioinformatics; 2015 Sep; 16():293. PubMed ID: 26373409
[TBL] [Abstract][Full Text] [Related]
39. Systemic sclerosis. A clinical overview.
Generini S; Fiori G; Moggi Pignone A; Matucci Cerinic M; Cagnoni M
Adv Exp Med Biol; 1999; 455():73-83. PubMed ID: 10599326
[TBL] [Abstract][Full Text] [Related]
40. Emerging biomarkers in systemic sclerosis.
Manetti M
Curr Opin Rheumatol; 2016 Nov; 28(6):606-12. PubMed ID: 27380110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
